Ward: Environment

230

FDA approves pill version of Novo Nordisk’s Wegovy, possibly widening access

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to be cleared by regulators for obesity.

123

STAT+: We’re reading about the first approved GLP-1 pill, deal-hungry Ipsen, and more

And more pharma news from the Pharmalot campus via the Pharmalittle newsletter

111

STAT+: Your health care industry 2025, wrapped

UnitedHealth fallout, Medicaid upheaval, and Medicare Advantage woes.

221

STAT+: 3 key issues to watch at FDA as Makary struggles to stabilize the agency

3 key issues to watch at FDA as Makary struggles to stabilize the agency

109

Opinion: 4 questions to understand the costs of ‘medical freedom’

The choice that one person makes not to vaccinate has real costs — financial and otherwise — for their neighbors.

120

Opinion: STAT+: What Ozempic might tell us about the future of Alzheimer’s

Someday, there will be a game-changing drug for Alzheimer’s. It’s worth thinking about that now.

311

The throughline between Ozempic and Prozac

And more health news from Morning Rounds today

329

How testosterone fell out of favor in medicine — and how it came back

And more health news from Morning Rounds

109

How testosterone fell out of favor in medicine — and how it came back

Abraham Morgentaler, a pioneer in testosterone therapy for men, discusses what led to decades of shunning of this hormone.

209

Study revives debate about unpopular diet for cancer patients

The neutropenic diet, which calls for nearly all food to be cooked at high heat to decrease infection risk, was waning in cancer care. A new study could change that.

331

STAT+: The best and worst drug names this year

And other biotech news, brought to you by The Readout newsletter

111

An advocate who offered a window on the experience of living with brain cancer dies at 43

Adam Hayden, a patient advocate and the subject of an earlier profile in STAT, has died at age 43.

239

STAT+: FDA flashpoints to watch next year

And other biotech news brought to you by The Readout

223

Take our quiz on the year in health and biotechnology

In just a couple of weeks, we’ll be bidding farewell to 2025. And what a year it has been! Artificial intelligence is being incorporated into more aspects of our lives, weight-loss drugs have expanded in scope, and there have been some real “omg” biotech stories from the fields of gene therapy, IVF,…

310

Second bird flu case confirmed on Queen Anne's County farm

Maryland officials have confirmed a second positive test for bird flu at a commercial poultry operation in Queen Anne's County, the 10th detection in the state in 2025, as public health experts warn the virus continues to pose a serious threat to animals—but remains a low risk for most people.

221

I Thought My Daughter Was a Good Kid, but a Certain Habit of Hers Disturbs Me

How can we nip this in the bud?

111

A new way to deliver antibodies could make treatment much easier for patients

Therapeutic antibodies packaged into microparticles could be injected with a standard syringe, avoiding the need for lengthy and often uncomfortable infusions.

111

One in eight of 14- to 17-year-olds in Great Britain say they have used nicotine pouches

Survey adds to experts’ concern about addiction risk and highlights support for plan to ban sales to under-18sOne in eight teenagers aged 14 to 17 have used nicotine pouches, a survey has found, adding to health experts’ concern about their growing popularity.Users hold the small sachets, which look…

109

The Birth Keepers: I choose this, episode one – podcast

The Free Birth Society was selling pregnant women a simple message: they could exit the medical system and take back their power by free birthing. But Nicole Garrison believes FBS ideology nearly cost her her life. This is episode one of a year-long investigation by the Guardian journalists Sirin Ka…

111

Don't call it a 'super flu' – but the NHS is right to be worried this winter | Devi Sridhar

An early flu season, a new variant and poor takeup of vaccines leave the already vulnerable health service in a dangerous positionProf Devi Sridhar is chair of global public health at the University of EdinburghYou might be feeling stressed out seeing the headlines about “super flu” and comparing th…